2 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 3 | 1 | Terminated 1 |
Follow HAIC: new trials by email Literature Review of HAIC trials Research Report on HAIC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC Radiotherapy, HAIC (GEMOX), Chemotherapy - Intrahepatic Cholangiocarcinoma | Phase 2 | Terminated | Shandong Cancer Hospital and Institute | 1 | 2024-04-01 | 2025-06-25 |
| Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial. HAIC, TACE, FOLFOX - Hepatocellular Carcinoma | Phase 2 / Phase 3 | Terminated | Peking University | 18 | 2021-12-24 | 2025-12-18 |
Carcinoma, Hepatocellular (1) · Cholangiocarcinoma (1)
Peking University (1) · Shandong Cancer Hospital and Institute (1)
China (2)
Jin Bo Yue, Dr. (1) · Xiaodong Wang, MD (1)
PMID 19491285, PMID 20375404, PMID 25111859, PMID 26695839, PMID 27095655, PMID 28596308, PMID 30785198, PMID 32372672, PMID 40812353